Objective: Among recently developed treatment strategies for advanced prostate cancer, 177Lu-PSMA-617–based radioligand therapy has shown considerable clinical potential in patients with metastatic castration-resistant disease. However, predictors of treatment response and survival outcomes remain incompletely defined....
Ebru Karcı, T. Atasever, Tansel Çakır et al.· Cerrahpasa Medical Journal· 0 citations
Background: The role of ^18F-FDG PET/CT in the initial staging of early-stage breast cancer remains controversial, as current guidelines discourage its routine use due to the low prevalence of distant metastases. This study aimed to evaluate the diagnostic yield and clinical impact of baseline PET/CT in a large multice...
M. A. Nazlı, O. Toktaş, S. Özbaş et al.· Breast Care· 0 citations
Purpose Androgen receptor (AR) expression is detectable in the majority of breast cancers across all molecular subtypes; however, its predictive value for pathological complete response (pCR) and its prognostic contribution to long-term survival in an all-comer neoadjuvant chemotherapy (NACT) cohort remain incompletely...
Harun Muğlu, V. B. Erol, H. Özçelik et al.· Breast Cancer· 0 citations
Data on the clinicopathological features of NRG1 fusion-positive non-small cell lung cancer (NSCLC) are limited. We conducted a retrospective, multicenter study and included patients with NRG1 fusion-positive NSCLC diagnosed between January 2018 and February 2025. Six patients were identified; five were female (83.3%),...
B. Köylü, N. Genc, M. H. Yücel et al.· Genes, Chromosomes and Cance...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
